Literature DB >> 32476914

Sarcoidosis with ankylosing spondylitis: changing therapeutic landscape.

Chinnabhathini Deva Rahul1, Rahul Kumar Sharma1, Deepak Talwar1.   

Abstract

Sarcoidosis is an inflammatory multisystem disease which rarely may coexist in patients with other autoimmune disease like ankylosing spondylitis (AS). The presence of such as association causes diagnostic and management dilemmas as sarcoidosis has been reported to develop in patients of AS treated with tumour necrosis factor alpha (TNF-α) inhibitors. We describe a 49-year-old male with ankylosing spondylitis and histologically proven sarcoidosis who was treated with infliximab and improved. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 285-288). Copyright:
© 2018.

Entities:  

Keywords:  TNF-α inhibitor; ankylosing spondylitis; infliximab; sarcoidosis

Year:  2018        PMID： 32476914      PMCID： PMC7170151          DOI： 10.36141/svdld.v35i3.6679

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN： 1124-0490            Impact factor:   0.670


  10 in total

Review 1.  Ankylosing spondylitis and sarcoidosis--coincidence or association? Case report and review of the literature.

Authors:  G Stucki; A von Felten; R Speich; B A Michel
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

2.  Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.

Authors:  R Almodóvar; M Izquierdo; P Zarco; F Javier Quirós; R Mazzucchelli; B Steen
Journal:  Clin Exp Rheumatol       Date:  2007 Jan-Feb       Impact factor: 4.473

Review 3.  [Sarcoidosis and ankylosing spondylitis. A case report and review of the literature].

Authors:  Ali Abouzahir; Abdellah El Maghraoui; Fatima Tabache; Ahmed Bezza; Jilali Chaari; Driss Ghafir; Victor Ohayon; Moulay-Idriss Archane
Journal:  Ann Med Interne (Paris)       Date:  2002-10

4.  New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.

Authors:  D Tong; N Manolios; G Howe; D Spencer
Journal:  Intern Med J       Date:  2012-01       Impact factor: 2.048

5.  Effectiveness of infliximab in treating selected patients with sarcoidosis.

Authors:  Samer Saleh; Shahriar Ghodsian; Violeta Yakimova; John Henderson; Om P Sharma
Journal:  Respir Med       Date:  2006-08-28       Impact factor: 3.415

6.  Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.

Authors:  Adriane D M Vorselaars; Heleen A Crommelin; Vera H M Deneer; Bob Meek; Anke M E Claessen; Ruth G M Keijsers; Coline H M van Moorsel; Jan C Grutters
Journal:  Eur Respir J       Date:  2015-04-30       Impact factor: 16.671

Review 7.  Sarcoidosis and spondylarthropathy. Three case-reports.

Authors:  P Kremer; E Gallinet; A Benmansour; J Despaux; E Toussirot; D Wendling
Journal:  Rev Rhum Engl Ed       Date:  1996-06

8.  Pulmonary sarcoidosis associated with etanercept therapy.

Authors:  Raymond E Farah; Moshe D Shay
Journal:  Pharmacotherapy       Date:  2007-10       Impact factor: 4.705

Review 9.  Recent advances in the treatment of the spondyloarthropathies.

Authors:  Yan Liu; Daniela Cortinovis; Millicent A Stone
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

Review 10.  Advances in the genetics of sarcoidosis.

Authors:  G Smith; I Brownell; M Sanchez; S Prystowsky
Journal:  Clin Genet       Date:  2008-02-26       Impact factor: 4.438
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.